InnovationRx: Recursion Launches Fund For Biotech Startups Hit By NIH Funding Cuts
Plus: A shift in bird flu strategy, a new vaccine for meningococcal disease, a new AI genomics model from Nvidia and more.
iRhythm reports Q4 adjusted EPS 1c, consensus (24c)
Reports Q4 revenue $164.325M, consensus $158.29M. “Our fourth quarter capped a transformative year for iRhythm (IRTC), marked by 24% revenue ...
The Globe and Mail1mon
iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference
“This past year was a period of significant growth and transformation for iRhythm,” said Quentin Blackford, iRhythm’s President and CEO. “In our core U.S. business, we achieved a record ...
uk.investing.com on MSN4mon
iRhythm shares soar after FDA clears Zio AT device updates
Quentin Blackford in a statement. Zio AT, iRhythm's mobile cardiac telemetry system, is designed to continuously monitor ...
Taiwan News1mon
iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference
“This past year was a period of significant growth and transformation for iRhythm,” said Quentin Blackford, iRhythm’s President and CEO. “In our core U.S. business, we achieved a record number of Zio ...